) to strong buy from buy.
) says Q4 software and total revenue will exceed its guidance and analyst expectations, with better than expected performance in revenue and adjusted EPS, or loss, per share.
Oracle Corp. (ORCL
) sees lower than expected $0.09 Q3 EPS and says year over year growth rates for software sales and operating income were about same as those for Q2. Merrill reportedly downgraded.
JP Morgan upgraded General Motors (GM
)to buy from market perform. DB Alex Brown reportedly raised estimates.
SoundView reiterated strong buy on Amkor Technology (AMKR
). On Friday the company said it is optimistic that Q2 could show a double-digit increase in assembly and test revenue from the Q1.
S&P downgraded FTI Consulting (FCN
) to accumulate from buy.
Northrop Grunman (NOC
) launched a hostile takeover bid for TRW Inc. (TRW
) after TRW's board rejected a friendly $6B ($47/share) offer.
IOS Brands Corp. will acquire the remaining shares of FTD.Com (EFTD
) it doesn't own.
CS First Boston reiterated strong buy on Capital One (COF
RBC Capital says February channel checks indicate strong sales by Nokia (NOK
) and reiterated Nokia as a top pick.
) set a 3-for-2 stock split.
UBS Warburg downgraded Lowes (LOW
) and Home Depot (HD
) to buy from strong buy.
JP Morgan downgraded JC Penney (JCP
) to market perform.
CIBC World reportedly upgraded Yahoo! (YHOO
) to buy from hold.
At&t Wireless (AWE
) Goldman removes from recommend list, and now rates market outperform; Goldman also cut the U.S. wireless sector to underweight. Morgan Stanley, Bear Stearns cut estimates. On Friday the company provided a negative forecast.
) reaffirmed guidance of $0.64-$0.70 2002 EPS on sales of $60M-$65M.
) posted 12% higher February same store sales, and 19% higher total sales.
Thoratec Corp. (THOR
) says trading in its stock will be halted today, pending today's review by an FDA advisory panel; the panel is reviewing the company's PMA Supplement for destination therapy based on the results of its REMATCH trial.
JP Realty (JPR
) agreed to be acquired by General Growth Properties in a cash deal valued at $1.1B, or $26.10 per share.
Boston Scientific (BSX
) says Medinol Ltd., its supplier of NIR stents, purports to terminate the supply pact between the companies. Medinol alleges that Boston Scientific breached the pact.
ICN Pharmaceutical (ICN
) says in light of questions that have been raised in recent days about a potential infringement on its ribavirin patent, it holds a very strong patent position, and that there is no NDA for ribavirin alone.
) is in a pact with Intel to distribute RealOne Player on Intel's newest PC desktop boards.
Toll Brothers (TOL
) set a 2-for-1 stock split.